Stronger Sell Today ARNA ranks #3681 as SELL CANDIDATE #3681 Weaker Sell

ARNA stock forecast Arena Pharmaceuticals

ARNA stock forecast

Friday December 13, 2019 Change -0.63% Price $47.02
Your prediction: Prediction: Request
VOLUME
Sell
TREND
Sell
MV LONG
Sell

MV SHORT
Sell

PIVOT
Buy

MACD
Buy

ARNA Forecast and Technical Stock Analysis


Sell candidate since 2019-12-11 Gain 0.26% PDF

Arena Pharmaceuticals fell by -0.63% in the last day ( Friday, 13th Dec 2019 ) from $47.32 to $47.02 During the day the stock fluctuated 3.61% from a day low at $46.80 to a day high of $48.49. The price has fallen in 6 of the last 10 days and is down by -0.76% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -44 512 shares and in total 300 472 shares bought and sold for approximately $14.13 million.

Quick summary:

  • 30 day high of the ARNA stock price was $49.78 and low was $44.65.
  • 90 day high was $52.73 and low was $43.09.
  • 52 week high for Arena Pharmaceuticals - $64.48 and low - $35.04.
Top Trending Stocks

Trend

Arena Pharmaceuticals lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.22% during the next 3 months and, with 90% probability hold a price between $42.09 and $47.67 at the end of this period.

Top Golden Star Stocks

Signals

There are mixed signals in the stock today. Arena Pharmaceuticals holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $47.59 and $47.56. A break-up above any of these levels will issue buy signals. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. A buy signal was issued from a pivot bottom point on Wednesday December 11, 2019, which indicates further gains until a new top pivot has been found.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 52 and the stock is currently not being overbought or oversold

* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.

Support & Resistance

Arena Pharmaceuticals finds support from accumulated volume at $46.90.

Support: $46.90 Price: $47.02 Resistance: $47.40

Risk

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.69 (3.61%) between high and low. For the last week, the stock has had daily average volatility of 3.12%.

Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.

3.12 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Sell Candidate Upgraded

Evaluation

Arena Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Stronger Sell Today ARNA ranks #3681 as SELL CANDIDATE #3681 Weaker Sell
Exchange: NASDAQ | NYSE | XLON | AMS | TSX | BRU

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

Proudly made at

ROCKIT